The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 study of MGTA-145 + plerixafor for rapid and reliable hematopoietic stem cell (HSC) mobilization for autologous transplant in multiple myeloma.
 
Surbhi Sidana
Consulting or Advisory Role - Janssen
Research Funding - Allogene Therapeutics (Inst); Janssen (Inst); Magenta Therapeutics (Inst)
 
Andriyana Bankova
No Relationships to Disclose
 
Hitomi Hosoya
No Relationships to Disclose
 
Lori S. Muffly
Stock and Other Ownership Interests - Corvus Pharmaceuticals
Honoraria - UpToDate
Consulting or Advisory Role - Amgen; Grail; Kite, a Gilead company; Pfizer
Research Funding - Adaptive Biotechnologies; Astellas Pharma; Jasper Therapeutics; Shire
 
Shaji Kumar
Consulting or Advisory Role - Abbvie (Inst); Abbvie (Inst); Amgen (Inst); Bluebird Bio (Inst); Celgene (Inst); Cellectar; Genecentrix; Genentech/Roche (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); Merck (Inst); Molecular Partners (Inst); Oncopeptides; Takeda (Inst)
Research Funding - Abbvie (Inst); CARsgen Therapeutics (Inst); Celgene (Inst); Janssen Oncology (Inst); Kite, a Gilead company (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Sanofi (Inst); Takeda (Inst); TeneoBio (Inst)
 
Laura J. Johnston
No Relationships to Disclose
 
Robert Lowsky
No Relationships to Disclose
 
Everett Meyer
Stock and Other Ownership Interests - GigaGen; Triursus Therapeutics
Consulting or Advisory Role - Incyte; Indee P/L; Jura Bio
Research Funding - Orca Bio
 
Andrew Rezvani
Research Funding - Pharmacyclics
 
Wen-Kai Weng
Research Funding - Kite/Gilead (Inst)
 
Sally Arai
No Relationships to Disclose
 
Matthew Joshua Frank
Employment - Roche/Genentech (I)
Stock and Other Ownership Interests - Roche/Genentech (I)
 
Parveen Shiraz
Research Funding - Kite/Gilead (Inst); Orca Bio (Inst)
 
Haley Howell
Employment - Magenta Therapeutics
Stock and Other Ownership Interests - Magenta Therapeutics
Patents, Royalties, Other Intellectual Property - Magenta Therapeutics
Travel, Accommodations, Expenses - Magenta Therapeutics
 
Kevin A Goncalves
Employment - Magenta Therapeutics
Stock and Other Ownership Interests - Magenta Therapeutics
Patents, Royalties, Other Intellectual Property - Magenta Therapeutics
Travel, Accommodations, Expenses - Magenta Therapeutics
 
Veit Schmelmer
Employment - Magenta Therapeutics
Stock and Other Ownership Interests - Magenta Therapeutics
Patents, Royalties, Other Intellectual Property - Magenta Therapeutics
Travel, Accommodations, Expenses - Magenta Therapeutics
Other Relationship - Mersana
 
John Davis
Employment - Magenta Therapeutics
Leadership - Magenta Therapeutics
Stock and Other Ownership Interests - Magenta Therapeutics
 
Judith Shizuru
Leadership - Jasper Therapeutics
Stock and Other Ownership Interests - Jasper Therapeutics
Consulting or Advisory Role - Jasper therapeutics
Research Funding - Magenta Therapeutics
Patents, Royalties, Other Intellectual Property - Stanford University (Inst)
Travel, Accommodations, Expenses - Jasper Therapeutics
 
David Bernard Miklos
Consulting or Advisory Role - Adaptive Biotechnologies; Alimera Sciences; Janssen; Juno/Celgene; Kite, a Gilead company; Miltenyi Biotec; Novartis; Pharmacyclics; Precision Biosciences
Research Funding - Adaptive Biotechnologies; Alimera Sciences; Kite, a Gilead company; Novartis; Novartis; Pharmacyclics; Precision Biosciences; Roche/Genentech
Patents, Royalties, Other Intellectual Property - Patent held with Pharmacyclics supporting Ibrutinib for cGVHD (no royalty claim)
Travel, Accommodations, Expenses - Adaptive Biotechnologies; Juno Therapeutics; Kite, a Gilead company; Miltenyi Biotec; Novartis; Pharmacyclics/Janssen